Hims & Hers Health Stock Is Crashing: Should You Buy the Dip?
Hims & Hers Health (NYSE: HIMS) has built its brand up in recent years by focusing on offering its customers products related to sensitive issues such as hair loss and erectile dysfunction. And it is looking at other opportunities, such as weight loss, that can accelerate its already high rate of growth. This can make it a potentially exciting stock for growth investors to hold in their portfolios.
But despite the opportunities ahead, the stock is struggling. It's down more than 30% in just three months. Investors appear to be less bullish on the stock as its strategy for the weight loss market can be a risky one, and its valuation is by no means cheap. Is the recent sell-off in Hims & Hers stock an attractive buying opportunity for investors, or is there a danger that shares of the telehealth company could go even lower?
What has undoubtedly attracted many investors to Hims & Hers stock in the past has been its impressive growth prospects. The telehealth company has been growing its subscriber base significantly (currently it has around 1.9 million subscribers) and that has helped it to rapidly grow its top line. And there's nothing like a high growth rate to get investors excited about a business.
Source Fool.com
